Study analysis · The Korean Journal of Pain · 2016
Women with fibromyalgia got a smaller endorphin rush after a hard workout—about 35 µg/mL less than healthy women—even though both groups improved.
In a small study, women with fibromyalgia had lower beta-endorphin levels at rest and after exercise, and their exercise-induced rise was blunted compared with healthy women.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is like taking two groups and checking their endorphin levels before and after exercise. It can show that fibromyalgia and lower endorphins are linked, but it can't prove that fibromyalgia causes low endorphins or that exercise changes them. It's a clue, not proof.
What’s the bottom line?
Scientists wanted to see if a hard workout changes a natural painkiller called beta-endorphin in women with fibromyalgia compared to healthy women. They tested 30 women with fibromyalgia and 15 healthy women on a treadmill and measured beta-endorphin before and after.
How strong is this study?
The study is small and the groups were not perfectly matched (the fibromyalgia group was older), so the results might be due to age or other differences. It's a starting point, but we need bigger, better studies to be sure.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
35 / 100
- Randomizationnot randomized
- Blinding+9/15
- Control group+15/15
- Sample size (n=45)+4.0/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 538 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a non-randomized cross-sectional comparative study with a pre-post exercise challenge. Without randomization, blinding of participants, and with significant age mismatch between groups, it cannot establish causal relationships. The observed differences in beta-endorphin levels could be due to fibromyalgia, age, or other unmeasured confounders. Temporal association is present for exercise but group differences may be pre-existing.
No Conflicts
No conflicts of interest identified
No conflicts of interest identified; no funding statement or industry ties disclosed.
Independent Analysis Safeguards
- Laboratory personnel were blinded to sample group and sequence of sample collection
No conflict of interest or funding statement was provided. Author names and affiliations are absent from the text, limiting assessment. The study was conducted at an academic institution (ACECER), and no industry funding or author-industry relationships are evident.
Key takeaways
- 01
Women with fibromyalgia had lower beta-endorphin at rest (90.12 vs 122.07 µg/mL, about 32 µg/mL lower) and after exercise (179.80 vs 246.55 µg/mL, about 67 µg/mL lower).
- 02
Exercise raised beta-endorphin in both groups, but the rise was smaller in fibromyalgia: +89.7 vs +124.5 µg/mL (about 35 µg/mL less).
- 03
They also reached the target heart rate faster (24.26 vs 29.06 minutes) and at lower treadmill stages.
- 04
These are absolute blood-level differences, not risk increases.
- 05
A 32–67 µg/mL lower beta-endorphin level is a real difference in this small study, but it is not known how much this changes pain or symptoms.
- 06
The study was small, groups were not age-matched, and it cannot prove cause and effect.
Surprising findings
- Exercise increased beta-endorphin in both groups, but the rise was significantly smaller in fibromyalgia.Common belief is that exercise gives a universal endorphin boost; this suggests a blunted response in chronic pain.
- Most fibromyalgia patients reached 70% max heart rate at early treadmill stages.Contradicts idea that they simply don't try hard; cardiovascular limitation appears early.
- Previous studies found no baseline beta-endorphin difference, but this one did.Shows how stress/exercise challenge may reveal differences hidden at rest.
- Authors say this is first study to assess beta-endorphin response to exercise in fibromyalgia.Novel but preliminary; no prior exercise-response data to compare against.
Practical takeaways
Don't use this study as a reason to avoid exercise if you have fibromyalgia—exercise still raised beta-endorphin in both groups.
Small cross-sectional study, no causality, age confound.
medium-low confidenceIf you have fibromyalgia, start exercise at low intensity and progress slowly; many participants reached target heart rate at early stages.
Not an intervention trial; individual responses vary.
low confidenceBe skeptical of blood endorphin tests claiming to measure brain pain relief.
Serum levels may not reflect central opioid activity.
medium confidenceAsk for age-matched research when interpreting fibromyalgia biomarkers.
Age correlated with beta-endorphin in this and prior studies.
low confidenceWhy this study matters
The Resting Endorphin Gap
In 30 women with fibromyalgia vs 15 healthy women, baseline serum beta-endorphin was 90.12 ± 20.91 vs 122.07 ± 28.56 µg/mL (P < 0.001). That is an ABSOLUTE difference of about 32 µg/mL lower in fibromyalgia. No relative risk is reported; this is not a risk study.
It suggests fibromyalgia may involve lower natural opioid tone, not just 'pain amplification' in the brain.
A Blunted Endorphin Rush After Exercise
After maximal treadmill exercise, beta-endorphin rose in both groups, but the absolute increase was +89.68 µg/mL in fibromyalgia vs +124.48 µg/mL in controls—an ABSOLUTE difference of about 35 µg/mL less. Post-exercise levels were 179.80 vs 246.55 µg/mL (absolute ~67 µg/mL lower).
Exercise is often recommended for fibromyalgia; this shows the biochemical reward may be smaller.
They Hit Target Heart Rate Sooner—and at Easier Stages
Women with fibromyalgia reached 70% predicted max heart rate in 24.26 ± 5.29 min vs 29.06 ± 3.26 min for controls (P < 0.003). 70% of FM patients reached it at modified Bruce stages 2–3 vs only 6.6% of controls (P < 0.0001).
This is objective evidence of exercise intolerance and may explain why workouts feel harder.
The Age Confound That Changes Everything
The fibromyalgia group was significantly older (41.7 ± 10.26 vs 30.67 ± 4.13 years; P < 0.001), and age is negatively correlated with beta-endorphin. The authors admit age may have contributed to baseline differences, though they argue the blunted post-exercise rise is less likely to be purely age.
It shows why you can't take a small cross-sectional study at face value.
Blood Endorphins May Not Reflect Brain Endorphins
The study measured serum beta-endorphin by HPLC, but the authors note that peripheral values 'may not reflect exactly its central activity.' The degree to which blood levels mirror brain opioid activity is an open challenge.
It affects how much we can infer about pain relief from a blood test.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists wanted to see if a hard workout changes a natural painkiller called beta-endorphin in women with fibromyalgia compared to healthy women. They tested 30 women with fibromyalgia and 15 healthy women on a treadmill and measured beta-endorphin before and after.
Research results
Women with fibromyalgia had lower beta-endorphin at rest (90.12 vs 122.07 µg/mL, about 32 µg/mL lower) and after exercise (179.80 vs 246.55 µg/mL, about 67 µg/mL lower). Exercise raised beta-endorphin in both groups, but the rise was smaller in fibromyalgia: +89.7 vs +124.5 µg/mL (about 35 µg/mL less). They also reached the target heart rate faster (24.26 vs 29.06 minutes) and at lower treadmill stages.
What this means - more context
These are absolute blood-level differences, not risk increases. A 32–67 µg/mL lower beta-endorphin level is a real difference in this small study, but it is not known how much this changes pain or symptoms. The study was small, groups were not age-matched, and it cannot prove cause and effect.
To investigate whether strenuous exercise changes serum beta-endorphin levels in women with fibromyalgia compared with healthy women.
In 30 women with fibromyalgia and 15 healthy women, baseline and post-exercise serum beta-endorphin were lower in fibromyalgia. Baseline: 90.12 ± 20.91 vs 122.07 ± 28.56 µg/mL (absolute difference ~31.95 µg/mL lower). Post-exercise: 179.80 ± 28.57 vs 246.55 ± 29.57 µg/mL (absolute difference ~66.75 µg/mL lower). Exercise increased beta-endorphin in both groups, but the absolute rise was smaller in fibromyalgia (+89.68 vs +124.48 µg/mL; absolute difference ~34.8 µg/mL less). Women with fibromyalgia also reached 70% predicted max heart rate sooner (24.26 vs 29.06 min) and at lower treadmill stages. No relative risks are reported; findings are cross-sectional and groups were not age-matched.
Methods Used
Single-center comparative study. 30 FM women (ACR 1990 criteria) and 15 healthy female volunteers (family members). Modified Bruce treadmill test to at least 70% predicted HRMax plus 15 min. Serum beta-endorphin measured by HPLC before and after exercise. Excluded psychotropic/opiate/hormonal therapy. Not age-matched.
Main Finding
Women with fibromyalgia had lower absolute serum beta-endorphin at baseline (90.12 vs 122.07 µg/mL; ~32 µg/mL lower) and after maximal exercise (179.80 vs 246.55 µg/mL; ~67 µg/mL lower). Exercise increased beta-endorphin in both groups, but the absolute increase was smaller in fibromyalgia (+89.68 vs +124.48 µg/mL; ~35 µg/mL less). They also had shorter exercise duration and reached target heart rate at lower stages. These are absolute concentration differences, not relative risks; no absolute risk per 1,000 people is applicable.
Confidence Level
Low to moderate. Small sample (45 total), no age matching (FM group older), cross-sectional design cannot establish causality. Serum beta-endorphin may not reflect central opioid activity. Psychiatric comorbidity not assessed. No retraction or corrections noted.
Study Flags
Red Flags
- •Small sample size (30 FM, 15 controls)
- •Groups not age-matched (FM group older)
- •Cross-sectional design cannot establish causality; peripheral beta-endorphin may not reflect central activity
Surprising Findings
Exercise increased beta-endorphin in both groups, but the rise was significantly smaller in fibromyalgia.
Common belief is that exercise gives a universal endorphin boost; this suggests a blunted response in chronic pain.
Practical Takeaways
Don't use this study as a reason to avoid exercise if you have fibromyalgia—exercise still raised beta-endorphin in both groups.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 538 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study is like taking two groups and checking their endorphin levels before and after exercise. It can show that fibromyalgia and lower endorphins are linked, but it can't prove that fibromyalgia causes low endorphins or that exercise changes them. It's a clue, not proof.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Controlled comparison between fibromyalgia patients and healthy controls
- Pre-post exercise measurements within same individuals
- Laboratory personnel blinded to sample group assignment
Weaknesses
- Non-randomized design with no allocation concealment
- Small sample size
- Groups not age-matched, introducing confounding
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists wanted to see if a hard workout changes a natural painkiller called beta-endorphin in women with fibromyalgia compared to healthy women. They tested 30 women with fibromyalgia and 15 healthy women on a treadmill and measured beta-endorphin before and after.
Research results
Women with fibromyalgia had lower beta-endorphin at rest (90.12 vs 122.07 µg/mL, about 32 µg/mL lower) and after exercise (179.80 vs 246.55 µg/mL, about 67 µg/mL lower). Exercise raised beta-endorphin in both groups, but the rise was smaller in fibromyalgia: +89.7 vs +124.5 µg/mL (about 35 µg/mL less). They also reached the target heart rate faster (24.26 vs 29.06 minutes) and at lower treadmill stages.
What this means - more context
These are absolute blood-level differences, not risk increases. A 32–67 µg/mL lower beta-endorphin level is a real difference in this small study, but it is not known how much this changes pain or symptoms. The study was small, groups were not age-matched, and it cannot prove cause and effect.
To investigate whether strenuous exercise changes serum beta-endorphin levels in women with fibromyalgia compared with healthy women.
In 30 women with fibromyalgia and 15 healthy women, baseline and post-exercise serum beta-endorphin were lower in fibromyalgia. Baseline: 90.12 ± 20.91 vs 122.07 ± 28.56 µg/mL (absolute difference ~31.95 µg/mL lower). Post-exercise: 179.80 ± 28.57 vs 246.55 ± 29.57 µg/mL (absolute difference ~66.75 µg/mL lower). Exercise increased beta-endorphin in both groups, but the absolute rise was smaller in fibromyalgia (+89.68 vs +124.48 µg/mL; absolute difference ~34.8 µg/mL less). Women with fibromyalgia also reached 70% predicted max heart rate sooner (24.26 vs 29.06 min) and at lower treadmill stages. No relative risks are reported; findings are cross-sectional and groups were not age-matched.
Methods Used
Single-center comparative study. 30 FM women (ACR 1990 criteria) and 15 healthy female volunteers (family members). Modified Bruce treadmill test to at least 70% predicted HRMax plus 15 min. Serum beta-endorphin measured by HPLC before and after exercise. Excluded psychotropic/opiate/hormonal therapy. Not age-matched.
Main Finding
Women with fibromyalgia had lower absolute serum beta-endorphin at baseline (90.12 vs 122.07 µg/mL; ~32 µg/mL lower) and after maximal exercise (179.80 vs 246.55 µg/mL; ~67 µg/mL lower). Exercise increased beta-endorphin in both groups, but the absolute increase was smaller in fibromyalgia (+89.68 vs +124.48 µg/mL; ~35 µg/mL less). They also had shorter exercise duration and reached target heart rate at lower stages. These are absolute concentration differences, not relative risks; no absolute risk per 1,000 people is applicable.
Confidence Level
Low to moderate. Small sample (45 total), no age matching (FM group older), cross-sectional design cannot establish causality. Serum beta-endorphin may not reflect central opioid activity. Psychiatric comorbidity not assessed. No retraction or corrections noted.
Study Flags
Red Flags
- •Small sample size (30 FM, 15 controls)
- •Groups not age-matched (FM group older)
- •Cross-sectional design cannot establish causality; peripheral beta-endorphin may not reflect central activity
Surprising Findings
Exercise increased beta-endorphin in both groups, but the rise was significantly smaller in fibromyalgia.
Common belief is that exercise gives a universal endorphin boost; this suggests a blunted response in chronic pain.
Practical Takeaways
Don't use this study as a reason to avoid exercise if you have fibromyalgia—exercise still raised beta-endorphin in both groups.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 538 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Human Cross-Sectional
Subject
Lower probability
on the GRADE evidence scale
This study is like taking two groups and checking their endorphin levels before and after exercise. It can show that fibromyalgia and lower endorphins are linked, but it can't prove that fibromyalgia causes low endorphins or that exercise changes them. It's a clue, not proof.
The study has a COI section but no disclosure was found. A small penalty has been applied.
Strengths
- Controlled comparison between fibromyalgia patients and healthy controls
- Pre-post exercise measurements within same individuals
- Laboratory personnel blinded to sample group assignment
Weaknesses
- Non-randomized design with no allocation concealment
- Small sample size
- Groups not age-matched, introducing confounding
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study is small and the groups were not perfectly matched (the fibromyalgia group was older), so the results might be due to age or other differences. It's a starting point, but we need bigger, better studies to be sure.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
35 / 100
- Randomizationnot randomized
- Blinding+9/15
- Control group+15/15
- Sample size (n=45)+4.0/20
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 538 / 100
Probability of being correct
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
This design cannot establish causation — the findings describe an association, not a cause. This is a non-randomized cross-sectional comparative study with a pre-post exercise challenge. Without randomization, blinding of participants, and with significant age mismatch between groups, it cannot establish causal relationships. The observed differences in beta-endorphin levels could be due to fibromyalgia, age, or other unmeasured confounders. Temporal association is present for exercise but group differences may be pre-existing.
No Conflicts
No conflicts of interest identified
No conflicts of interest identified; no funding statement or industry ties disclosed.
Independent Analysis Safeguards
- Laboratory personnel were blinded to sample group and sequence of sample collection
No conflict of interest or funding statement was provided. Author names and affiliations are absent from the text, limiting assessment. The study was conducted at an academic institution (ACECER), and no industry funding or author-industry relationships are evident.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
5 researchersIf this is your work, this is how we attribute it on Fit Body Science. Ali Bidari is listed as the lead author.